Ficha del valor · trimestre archivado
SPRY
ARS Pharmaceuticals, Inc. · Healthcare · Biotechnology
14Tenedores rastreados
0Δ titulares
19.24MAcciones mantenidas
$335.74MValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +30.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +1 | 32.54M | $260.86M | +8 | −7 |
| Q1 2026 | 76 | +2 | 39.92M | $320.66M | +9 | −7 |
| Q4 2025 | 74 | +1 | 37.60M | $438.08M | +2 | −1 |
| Q3 2025 | 13 | -4 | 17.49M | $175.83M | +1 | −5 |
| Q2 2025 | 14 | 0 | 19.24M | $335.74M | +1 | −1 |
| Q1 2025 | 11 | +2 | 5.28M | $66.41M | +2 | — |
| Q4 2024 | 9 | -2 | 6.14M | $64.82M | — | −2 |
| Q3 2024 | 10 | +2 | 3.52M | $51.10M | +3 | −1 |
| Q2 2024 | 8 | — | 1.67M | $14.24M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 4.42M | — | $77.19M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 3.26M | — | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 3.26M | — | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 3.26M | — | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 3.26M | — | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 3.26M | — | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 2.24M | +179.8% | $39.13M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (pasivo) | 2.19M | +8.0% | $38.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 1.73M | Nuevo | $30.15M | 0.1% | New | 1 | SEC ↗ |
| 20 | Fidelity (FMR) ✦ | 1.57M | — | $27.34M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Fidelity (FMR) ✦ | 1.57M | — | $27.34M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 1.43M | +987.6% | $25.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 1.43M | +987.6% | $25.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 1.43M | +987.6% | $25.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.43M | +987.6% | $25.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Wellington Management ✦ | 1.43M | +987.6% | $25.01M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (pasivo) | 1.34M | +6.5% | $23.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (pasivo) | 1.34M | +6.5% | $23.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Millennium Management ✦ | 878.16K | +8.8% | $15.32M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 57.45K | +70.0% | $1.00M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 57.45K | +70.0% | $1.00M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Marshall Wace ✦ | 39.91K | -74.5% | $696,500 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | Marshall Wace ✦ | 39.91K | -74.5% | $696,500 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | T. Rowe Price ✦ | 27.39K | +25.9% | $478,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Gotham Asset Management ✦ | 27.26K | +109.2% | $475,617 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 16.13K | +45.1% | $281,503 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 16.13K | +45.1% | $281,503 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 16.13K | +45.1% | $281,503 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 16.13K | +45.1% | $281,503 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 16.13K | +45.1% | $281,503 | 0.0% | ▲ Add | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Adage Capital Partners | $30.15M | 0.1% |
Posición cerrada
| Two Sigma Investments | $135,499 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 201 tenedores, 92.94M acciones, $730.00M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API